The prevalence and clinical relevance of 2R/2R TYMS genotype in patients with gastrointestinal malignancies treated with fluoropyrimidine-based chemotherapy regimens.

Pharmacogenomics J · 2021 · PMC8159739 · PMID 33608662

Europe PMC DOI

hedged sentence

0.1108

closest p · 2.2× alpha

0.1108

boldest claim

The sentences

did not reach statistical significancep = 0.1108not close (p > 0.1)

The association between the other genotypes ( 2R/3RC and 3RC/3RC TYMS genotypes) and grade 3–4 FrAEs did not reach statistical significance ( p = 0.1108).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.